ALSO NOTED: Tanox touts new data; Boehringer Ingelheim wins EU OK; Tibotec expands program; and much more...

> Tanox reported positive Phase II data for its HIV drug candidate. Release

> Boehringer Ingelheim has received EU approval to market Aptivus for HIV. Release

> Tibotec Pharmaceuticals has announced the opening of its expanded access program (EAP) for its investigational protease inhibitor. Release

> Idera Pharmaceuticals has begun a Phase I/II trial of HYB2055 in combination with the chemotherapy agents gemcitabine and carboplatin. Release

And Finally... Health literacy experts are worried that many consumers rely too much on drug labels. Report